This site is intended for healthcare professionals
thymoma, a tumor of thymic gland origin with both epithelial and lymphoid components, cell image, pink and purple colours
Myasthenia Gravis Learning Zone

Transcript: The push for better MG care

Last updated: 6th Jun 2024
Published: 6th Jun 2024

Dr Renato Mantegazza and Domenico Montalto

Interview recorded Apr 2024. All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speaker and is not adjusted by Medthority.

If you have to give a vote to the health system that has taken care of you from zero, very bad, to ten, very good. How do you will vote for your personal experience? Actually, I have to split the vote in two parts. The hospital, I can give four, but the professionals, I can give nine or ten, so. Okay, from your answer, I can actually understand that one of the big problem that patients are facing is to have a better quality of management in terms of taking care, places where to do the visits and how easy is to book a reservation, how easy is to get access to the hospital or to the outpatient.

Treatments, hospitals, they depend from hospitals, from healthcare in general. But we have qualified professionals, very qualified professional, that try every day to help us in every way. So ten for them. And do you think that the. Ten for you. Do you think the Patient's Association is useful for patients or did the Patient's Association did anything for you? Yes, absolutely.

Until today we fought against all the bureaucracy that there is behind all step for treatment or for management, for professionals that are not enough for us, for example, in Palermo, the centre is getting bigger than before, but we have not enough professional that can take care of us. So we are fighting. As a matter of fact, in the past, we have seen a lot of health migration from the south to the north of Italy because of these problems. And although the real problem is to set up optimal conditions to treat these rare diseases because myasthenia is a rare and a chronic disease. And since, I mean, there are very low percentages of that due to myasthenia, people, a person, a patient can live for a very long time with this disease. So it is clear that we have to adapt to improve the condition of managing these patients.

View the video

 

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.